| scholarly article | Q13442814 |
| P50 | author | Dana Pe'er | Q16204043 |
| Bernhard Reis | Q37615006 | ||
| Bernd Bodenmiller | Q88700613 | ||
| Holger Moch | Q90210393 | ||
| P2093 | author name string | Marina Bacac | |
| Karina Silina | |||
| Maries van den Broek | |||
| Christian Beisel | |||
| Stéphane Chevrier | |||
| Laurie Ailles | |||
| Craig Gedye | |||
| Daniel Schulz | |||
| Vito Riccardo Tomaso Zanotelli | |||
| Michael Beda Stadler | |||
| Carola Hermine Ries | |||
| Jacob Harrison Levine | |||
| Michael Alexander Spencer Jewett | |||
| P2860 | cites work | Molecular and cellular insights into T cell exhaustion | Q26800047 |
| CD4+/CD8+ double-positive T cells: more than just a developmental stage? | Q26821885 | ||
| Immune cell promotion of metastasis | Q26991724 | ||
| Towards the introduction of the 'Immunoscore' in the classification of malignant tumours | Q27026489 | ||
| Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy | Q27690653 | ||
| Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion | Q27860475 | ||
| edgeR: a Bioconductor package for differential expression analysis of digital gene expression data | Q27860819 | ||
| Immunity, Inflammation, and Cancer | Q27861048 | ||
| Type, density, and location of immune cells within human colorectal tumors predict clinical outcome | Q28131662 | ||
| STAR: ultrafast universal RNA-seq aligner | Q29615052 | ||
| Macrophage diversity enhances tumor progression and metastasis | Q29615847 | ||
| Natural innate and adaptive immunity to cancer | Q29620313 | ||
| T cell exhaustion | Q29620463 | ||
| Macrophage activation and polarization: nomenclature and experimental guidelines | Q29620642 | ||
| Normalization of mass cytometry data with bead standards | Q30604177 | ||
| viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia | Q30628090 | ||
| Diffusion maps for high-dimensional single-cell analysis of differentiation data. | Q30957322 | ||
| Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis | Q30975629 | ||
| destiny: diffusion maps for large-scale single-cell data in R. | Q31032129 | ||
| Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling | Q33240546 | ||
| Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired | Q34080914 | ||
| Web-based analysis and publication of flow cytometry experiments | Q34122689 | ||
| Highly multiparametric analysis by mass cytometry | Q34127700 | ||
| Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression | Q34168497 | ||
| Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators | Q34294698 | ||
| Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse | Q34516665 | ||
| Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. | Q34659689 | ||
| Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry | Q34992218 | ||
| CSF-1R inhibition alters macrophage polarization and blocks glioma progression | Q34993852 | ||
| Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry | Q35105312 | ||
| Palladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithm | Q35141765 | ||
| Immune signature of tumor infiltrating immune cells in renal cancer | Q35201895 | ||
| CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients | Q35833077 | ||
| Novel Markers to Delineate Murine M1 and M2 Macrophages | Q35877268 | ||
| Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection | Q36077705 | ||
| CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer | Q36118086 | ||
| CD38 deficiency in the tumor microenvironment attenuates glioma progression and modulates features of tumor-associated microglia/macrophages. | Q36127405 | ||
| Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer. | Q36383090 | ||
| Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy | Q36830759 | ||
| Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma | Q36849038 | ||
| Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells Predict Distant Metastatic Relapse and Survival of Clear Cell Renal Cell Carcinoma | Q36865032 | ||
| Dual role of CD38 in microglial activation and activation-induced cell death. | Q36931725 | ||
| Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq | Q37094024 | ||
| Macrophage polarization in tumour progression | Q37158140 | ||
| A platinum-based covalent viability reagent for single-cell mass cytometry. | Q37257000 | ||
| Molecular aspects of renal cell carcinoma: a review | Q37942072 | ||
| CD169+ macrophages at the crossroads of antigen presentation | Q37970844 | ||
| Chemokines and chemokine receptors: positioning cells for host defense and immunity | Q38198156 | ||
| Tumor-associated macrophages: from mechanisms to therapy | Q38230880 | ||
| The evolution of checkpoint blockade as a cancer therapy: what's here, what's next? | Q38332778 | ||
| Macrophages and cancer: from mechanisms to therapeutic implications | Q38377725 | ||
| It's DE-licious: A Recipe for Differential Expression Analyses of RNA-seq Experiments Using Quasi-Likelihood Methods in edgeR. | Q38449509 | ||
| Prognostic factors and risk classifications for patients with metastatic renal cell carcinoma | Q38543085 | ||
| Regulatory circuits of T cell function in cancer | Q38928127 | ||
| Inhibition of glioma progression by a newly discovered CD38 inhibitor. | Q38972612 | ||
| Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma. | Q39155704 | ||
| Nivolumab treatment for advanced renal cell carcinoma: Considerations for clinical practice. | Q39161606 | ||
| Clinical significance of CD163⁺ tumor-associated macrophages in patients with adult T-cell leukemia/lymphoma | Q39171301 | ||
| Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma. | Q39489706 | ||
| New insights into the multidimensional concept of macrophage ontogeny, activation and function. | Q40866271 | ||
| Transient partial permeabilization with saponin enables cellular barcoding prior to surface marker staining | Q41861472 | ||
| AirLab: a cloud-based platform to manage and share antibody-based single-cell research | Q42482102 | ||
| QuasR: quantification and annotation of short reads in R. | Q43213442 | ||
| CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma. | Q43899944 | ||
| Prognostic value of diametrically polarized tumor-associated macrophages in renal cell carcinoma | Q46223371 | ||
| CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. | Q55053710 | ||
| A practical guide to multiplexed mass cytometry | Q87205346 | ||
| P4510 | describes a project that uses | ggplot2 | Q326489 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 736-749.e18 | |
| P577 | publication date | 2017-05-01 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | An Immune Atlas of Clear Cell Renal Cell Carcinoma | |
| P478 | volume | 169 |
| Q96823744 | A Cancer Biologist's Primer on Machine Learning Applications in High-Dimensional Cytometry |
| Q64267406 | A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer |
| Q48652546 | A drug development perspective on targeting tumor-associated myeloid cells. |
| Q57180545 | A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosis |
| Q55062993 | A richer understanding of intratumoral heterogeneity: single-cell genomics put it within reach. |
| Q94671894 | A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors |
| Q52321225 | Advancing systems immunology through data-driven statistical analysis. |
| Q64988868 | Analysis of the Human Kinome and Phosphatome by Mass Cytometry Reveals Overexpression-Induced Effects on Cancer-Related Signaling. |
| Q100425520 | Application of Single-Cell Sequencing to Immunotherapy |
| Q97570273 | Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma |
| Q92978709 | B cells, plasma cells and antibody repertoires in the tumour microenvironment |
| Q89613146 | Basophils in Tumor Microenvironment and Surroundings |
| Q90483929 | Beyond the message: advantages of snapshot proteomics with single-cell mass cytometry in solid tumors |
| Q57694776 | Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates |
| Q89821709 | CD163+ tumor-associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes |
| Q89556582 | CD8+ T cell states in human cancer: insights from single-cell analysis |
| Q49561501 | Cancer Associated Fibroblasts: The Architects of Stroma Remodeling. |
| Q60933076 | Cancer research in the era of immunogenomics |
| Q97546137 | Cancer systems immunology |
| Q53777929 | Cell maps reveal fresh details on how the immune system fights cancer. |
| Q49535639 | CellCycleTRACER accounts for cell cycle and volume in mass cytometry data. |
| Q46243039 | Characterisation of the immune-related transcriptome in resected biliary tract cancers |
| Q106957867 | Characterization of Renal Cell Carcinoma Heterotypic 3D Co-Cultures with Immune Cell Subsets |
| Q97905754 | Characterizing the ecological and evolutionary dynamics of cancer |
| Q101216963 | Clear cell renal cell carcinoma ontogeny and mechanisms of lethality |
| Q98183378 | Coagulation signaling and cancer immunotherapy |
| Q52616271 | Compensation of Signal Spillover in Suspension and Imaging Mass Cytometry. |
| Q64288108 | Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma |
| Q52606456 | Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma. |
| Q90664808 | Computational Analysis of DNA and RNA Sequencing Data Obtained from Liquid Biopsies |
| Q58562104 | Computational immune monitoring reveals abnormal double negative T cells present across human tumor types |
| Q61451353 | Construction of immune-related risk signature for renal papillary cell carcinoma |
| Q91013849 | Context-dependent roles of complement in cancer |
| Q58746454 | Continuous Immune Cell Differentiation Inferred From Single-Cell Measurements Following Allogeneic Stem Cell Transplantation |
| Q92385233 | CyTOFmerge: integrating mass cytometry data across multiple panels |
| Q92637601 | Cellular censuses to guide cancer care |
| Q92312886 | Deciphering Immune-Associated Genes to Predict Survival in Clear Cell Renal Cell Cancer |
| Q92757978 | Development and validation of a robust multigene signature as an aid to predict early relapse in stage I-III clear cell and papillary renal cell cancer |
| Q57817490 | Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy |
| Q91594396 | Dissecting intratumoral myeloid cell plasticity by single cell RNA-seq |
| Q88963825 | Distant Relations: Macrophage Functions in the Metastatic Niche |
| Q47958949 | Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade |
| Q48150040 | Enhanced gastric cancer growth potential of mesenchymal stem cells derived from gastric cancer tissues educated by CD4(+) T cells. |
| Q47225787 | Eosinophils: The unsung heroes in cancer? |
| Q96133768 | Epidemiology of Renal Cell Carcinoma |
| Q52309964 | Expanding the therapeutic index of radiation therapy by normal tissue protection. |
| Q90576457 | Exploring single-cell data with deep multitasking neural networks |
| Q58614050 | From single cells to tissue self-organization |
| Q64884539 | Functional genomics: paving the way for more successful cancer immunotherapy. |
| Q89994640 | Future Needs in Mast Cell Biology |
| Q98513545 | HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice |
| Q49296790 | HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape. |
| Q64956346 | Heavy Metal Enlightens Tumor Immunity. |
| Q100503062 | High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer |
| Q52716744 | High-Dimensional Phenotyping Identifies Age-Emergent Cells in Human Mammary Epithelia. |
| Q46318813 | High-dimension single-cell analysis applied to cancer |
| Q91592597 | High-dimensional cytometric analysis of colorectal cancer reveals novel mediators of antitumour immunity |
| Q89601476 | High-dimensional immune-profiling in cancer: implications for immunotherapy |
| Q38666877 | High-dimensional single cell mapping of cerium distribution in the lung immune microenvironment of an active smoker. |
| Q92316756 | Human Tumor-Infiltrating Dendritic Cells: From in Situ Visualization to High-Dimensional Analyses |
| Q60912837 | Human bone marrow assessment by single-cell RNA sequencing, mass cytometry, and flow cytometry |
| Q89577163 | Identification of an immune-related risk signature for predicting prognosis in clear cell renal cell carcinoma |
| Q92244861 | Identification of four immune subtypes characterized by distinct composition and functions of tumor microenvironment in intrahepatic cholangiocarcinoma |
| Q93140000 | Identification of prognosis-related alternative splicing events in kidney renal clear cell carcinoma |
| Q94475277 | Identification of the immune checkpoint signature of multiple myeloma using mass cytometry-based single-cell analysis |
| Q98291749 | Immune Cell Infiltration and Identifying Genes of Prognostic Value in the Papillary Renal Cell Carcinoma Microenvironment by Bioinformatics Analysis |
| Q64244455 | Immune Profiling and Precision Medicine in Systemic Lupus Erythematosus |
| Q50026313 | Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma. |
| Q64101974 | Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer |
| Q64068859 | Immune infiltration in renal cell carcinoma |
| Q92229967 | Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma |
| Q92827384 | Immunomodulatory effect of mesenchymal stem cells in chemical-induced liver injury: a high-dimensional analysis |
| Q58123214 | Immunophenotyping of Orthotopic Homograft (Syngeneic) of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry |
| Q56362292 | Implementation of Mass Cytometry as a Tool for Mechanism of Action Studies in Inflammatory Bowel Disease |
| Q59349994 | Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus-Driven Production of a Bispecific T-cell Engager |
| Q61796386 | In-Depth Characterization of Monocyte-Derived Macrophages using a Mass Cytometry-Based Phagocytosis Assay |
| Q96023037 | Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma |
| Q97532333 | Isotopically Encoded Nanotags for Multiplexed Ion Beam Imaging |
| Q92418418 | JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors |
| Q93165941 | Key steps and methods in the experimental design and data analysis of highly multi-parametric flow and mass cytometry |
| Q93063710 | Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry |
| Q63915886 | Macrophages and Cardiovascular Health |
| Q52321369 | Macrophages: The Road Less Traveled, Changing Anticancer Therapy. |
| Q92965128 | Mass cytometry dissects T cell heterogeneity in the immune tumor microenvironment of common dysproteinemias at diagnosis and after first line therapies |
| Q64814783 | Mass synaptometry: High-dimensional multi parametric assay for single synapses |
| Q64990427 | Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer. |
| Q91785787 | Metal-isotope-tagged monoclonal antibodies for high-dimensional mass cytometry |
| Q97526249 | Microenvironment-related gene TNFSF13B predicts poor prognosis in kidney renal clear cell carcinoma |
| Q91857347 | Microlocalization and clinical significance of stabilin-1+ macrophages in treatment-naïve patients with urothelial carcinoma of the bladder |
| Q91436230 | Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment |
| Q92372097 | Molecular Classification of Renal Cell Carcinoma and Its Implication in Future Clinical Practice |
| Q107270365 | Molecular and Functional Analysis of Sunitinib-Resistance Induction in Human Renal Cell Carcinoma Cells |
| Q57818011 | Multi-Omics Profiling of the Tumor Microenvironment: Paving the Way to Precision Immuno-Oncology |
| Q90196801 | Myeloid cell-synthesized coagulation factor X dampens antitumor immunity |
| Q92052235 | Myeloid-Derived Suppressor Cells: Major Figures that Shape the Immunosuppressive and Angiogenic Network in Cancer |
| Q89510977 | NK Cell-Based Immunotherapy in Renal Cell Carcinoma |
| Q92705028 | Negative Co-stimulation Constrains T Cell Differentiation by Imposing Boundaries on Possible Cell States |
| Q98720608 | New technology on the horizon: Fast analytical screening technique FNA (FAST-FNA) enables rapid, multiplex biomarker analysis in head and neck cancers |
| Q50249667 | Nonresolving macrophage-mediated inflammation in malignancy. |
| Q52709354 | OMIP-044: 28-color immunophenotyping of the human dendritic cell compartment. |
| Q64119748 | Organoid Modeling of the Tumor Immune Microenvironment |
| Q104576046 | Origins and diversity of macrophages in health and disease |
| Q38651976 | Papillary renal cell carcinoma-derived chemerin, IL-8, and CXCL16 promote monocyte recruitment and differentiation into foam-cell macrophages. |
| Q55709201 | Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy). |
| Q50017705 | Phenotypical change of tumor-associated macrophages in metastatic lesions of clear cell renal cell carcinoma. |
| Q91935927 | Picturing Polarized Myeloid Phagocytes and Regulatory Cells by Mass Cytometry |
| Q92303826 | Predicting Cell Populations in Single Cell Mass Cytometry Data |
| Q95591987 | Preface: More than two decades of modern tumor immunology |
| Q89450684 | Preface: More than two decades of modern tumor immunology |
| Q91284516 | Preface: More than two decades of modern tumor immunology |
| Q57144510 | Present and future of cancer immunotherapy: A tumor microenvironmental perspective |
| Q90477375 | Programmed death ligand-1 is associated with tumor infiltrating lymphocytes and poorer survival in urothelial cell carcinoma of the bladder |
| Q101149107 | Progress and applications of mass cytometry in sketching immune landscapes |
| Q58104090 | Progress in Kidney Cancer Outcomes Through Collaboration, Innovation, and Discovery |
| Q90168559 | Qualifying antibodies for image-based immune profiling and multiplexed tissue imaging |
| Q91692062 | Quantifying in situ adaptive immune cell cognate interactions in humans |
| Q57492123 | Quantitative Analyses of the Tumor Microenvironment Composition and Orientation in the Era of Precision Medicine |
| Q39423479 | Regulatory myeloid cells: an underexplored continent in B-cell lymphomas |
| Q92799074 | Relationship of B7-H3 expression in tumor cells and tumor vasculature with FOXP3+ regulatory T cells in renal cell carcinoma |
| Q59808681 | Renal Cell Carcinoma (RCC) Tumors Display Large Expansion of Double Positive (DP) CD4+CD8+ T Cells With Expression of Exhaustion Markers |
| Q92815283 | Resistance to Systemic Agents in Renal Cell Carcinoma Predict and Overcome Genomic Strategies Adopted by Tumor |
| Q89746804 | Revisiting Immunotherapy: A Focus on Prostate Cancer |
| Q90284285 | Self-organization and symmetry breaking in intestinal organoid development |
| Q91712001 | Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors |
| Q89367617 | Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment |
| Q64120217 | Single-cell RNA sequencing of lung adenocarcinoma reveals heterogeneity of immune response-related genes |
| Q91834199 | Single-cell technologies - studying rheumatic diseases one cell at a time |
| Q64987525 | Single-cell technologies for profiling T cells to enable monitoring of immunotherapies. |
| Q92376163 | Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression |
| Q91780901 | Stabilizing Antibody Cocktails for Mass Cytometry |
| Q98771256 | Synergies of Antiangiogenic Therapy and Immune Checkpoint Blockade in Renal Cell Carcinoma: From Theoretical Background to Clinical Reality |
| Q56535000 | Systems Immunology: Learning the Rules of the Immune System |
| Q52596337 | T Cell Dysfunction in Cancer. |
| Q91565659 | Targeting Tumor Microenvironment by Small-Molecule Inhibitors |
| Q55299267 | Targeting the Immune Microenvironment in Acute Myeloid Leukemia: A Focus on T Cell Immunity. |
| Q89510215 | Targeting the Immune system and Epigenetic Landscape of Urological Tumors |
| Q64968881 | Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and Therapy. |
| Q64921356 | The B-side of Cancer Immunity: The Underrated Tune. |
| Q91666595 | The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications |
| Q89921484 | The Disturbed Iron Phenotype of Tumor Cells and Macrophages in Renal Cell Carcinoma Influences Tumor Growth |
| Q92619376 | The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition |
| Q52679182 | The Peripheral and Intratumoral Immune Cell Landscape in Cancer Patients: A Proxy for Tumor Biology and a Tool for Outcome Prediction. |
| Q52618381 | The Warburg Effect in Diabetic Kidney Disease. |
| Q57045495 | The anatomy of single cell mass cytometry data |
| Q91089808 | The end of omics? High dimensional single cell analysis in precision medicine |
| Q90590486 | The expanding landscape of inflammatory cells affecting cancer therapy |
| Q96952246 | The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications |
| Q90617765 | The human body at cellular resolution: the NIH Human Biomolecular Atlas Program |
| Q98177248 | The immunology of renal cell carcinoma |
| Q91559722 | The microcosmos of intratumor heterogeneity: the space-time of cancer evolution |
| Q49684254 | The roles of CSFs on the functional polarization of tumor-associated macrophages. |
| Q93094713 | The tumor microenvironment in renal cell cancer |
| Q93139113 | Towards individualized therapy for metastatic renal cell carcinoma |
| Q97523820 | Trajectory and Functional Analysis of PD-1high CD4+CD8+ T Cells in Hepatocellular Carcinoma by Single-Cell Cytometry and Transcriptome Sequencing |
| Q90643605 | Transcriptional profiling of tumor associated macrophages in human renal cell carcinoma reveals significant heterogeneity and opportunity for immunomodulation |
| Q47325431 | Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications |
| Q90131626 | Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma |
| Q64261371 | Tumor cells induce LAMP2a expression in tumor-associated macrophage for cancer progression |
| Q92912501 | Tumor-associated macrophage expression of interferon regulatory Factor-8 (IRF8) is a predictor of progression and patient survival in renal cell carcinoma |
| Q89983220 | Tumor-educated B cells promote renal cancer metastasis via inducing the IL-1β/HIF-2α/Notch1 signals |
| Q92936015 | Tumor-infiltrating M2 macrophage in pretreatment biopsy sample predicts response to chemotherapy and survival in esophageal cancer |
| Q90468410 | Tumor-infiltrating neutrophils predict therapeutic benefit of tyrosine kinase inhibitors in metastatic renal cell carcinoma |
| Q91817083 | Tumour grade significantly correlates with total dysfunction of tumour tissue-infiltrating lymphocytes in renal cell carcinoma |
| Q88161272 | Tumour immunology: Immune atlas sheds light on anticancer responses |
| Q92556918 | Tuning the Tumor Myeloid Microenvironment to Fight Cancer |
| Q96945876 | Turning Cold into Hot: Firing up the Tumor Microenvironment |
| Q92611103 | Uncovering axes of variation among single-cell cancer specimens |
| Q59795605 | Understanding tumor ecosystems by single-cell sequencing: promises and limitations |
| Q89653483 | Unfolding innate mechanisms in the cancer microenvironment: The emerging role of the mesenchyme |
| Q47951823 | Unmassked: Single-Cell Profiling of Immune Cell Populations in Tumors |
| Q98466291 | Unraveling the Complexity of the Cancer Microenvironment With Multidimensional Genomic and Cytometric Technologies |
| Q89621125 | Use of Mass Cytometry to Profile Human T Cell Exhaustion |
| Q91517668 | Ushering in Integrated T Cell Repertoire Profiling in Cancer |
| Q91934527 | Using single-cell technologies to map the human immune system - implications for nephrology |
| Q97067536 | [Impact of molecular signatures on the choice of systemic treatment for metastatic kidney cancer] |
Search more.